Abstract

The oudemansielloid/xeruloid taxa Hymenopellis, Mucidula, Oudemansiella, and Xerula are genera of Basidiomycota that constitute an important resource of bioactive compounds. Numerous studies have shown antimicrobial, anti-oxidative, anti-cancer, anti-inflammatory and other bioactivities of their extracts. The bioactive principles can be divided into two major groups: (a) hydrophilic polysaccharides with relatively high molecular weights and (b) low molecular medium polar secondary metabolites, such as the antifungal strobilurins. In this review, we summarize the state of the art on biodiversity, cultivation of the fungi and bioactivities of their secondary metabolites and discuss future applications. Although the strobilurins are well-documented, with commercial applications as agrochemical fungicides, there are also other known compounds from this group that have not yet been well-studied. Polysaccharides, dihydro-citrinone phenol A acid, scalusamides, and acetylenic lactones such as xerulin, also have potential applications in the nutraceutical, pharmaceutical and medicinal market and should be further explored. Further studies are recommended to isolate high quality bioactive compounds and fully understand their modes of action. Given that only few species of oudemansielloid/xeruloid mushrooms have been explored for their production of secondary metabolites, these taxa represent unexplored sources of potentially useful and novel bioactive metabolites.

Highlights

  • Basidiomycota, especially mushrooms, have been explored for thousands of years for their nutritional value and as therapeutic agents [1,2]

  • This paper aims to explore the OX group of mushrooms as sources of bioactive compounds

  • Basidiomycota have long been recognized as sources of interesting secondary metabolites; because of the slow mycelial growth and diverse nutritional requirements they were often been neglected as a source of important bioactive compounds [5,81]

Read more

Summary

A Review

Allen Grace Niego 1,2,3 , Olivier Raspé 1,2 , Naritsada Thongklang 1,2 , Rawiwan Charoensup 4,5 , Saisamorn Lumyong 6,7,8 , Marc Stadler 9,10, * and Kevin D. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Medicinal Plants Innovation Center, Mae Fah Luang University, Chiang Rai 57100, Thailand. Research Center of Microbial Diversity and Sustainable Utilization, Chiang Mai University, Chiang Mai 50200, Thailand. Department Microbial Drugs, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany. German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany

Introduction
Hymenopellis
Xerula
Cultivation of Important Species with Bioactivities
Basidiomata
Cultivation
Cultivation of Mucidula
Cultivation of Oudemansiella
Cultivation of Xerula
Bioactivities and Mode of Action
Chemical
Biosynthesis of Strobilurins and Total Synthesis of Xerulins
Market
Findings
Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call